Literature DB >> 22841790

Steroid 21-hydroxylase gene mutational spectrum in 50 Tunisian patients: characterization of three novel polymorphisms.

Ilhem Ben Charfeddine1, Felix G Riepe, Eric Clauser, Abdelkarim Ayedi, Saloua Makni, Mohamed Tahar Sfar, Hassen Sboui, Najoua Kahloul, Hechmi Ben Hamouda, Slaheddine Chouchane, Sihem Trimech, Noura Zouari, Samir M'Rabet, Fathi Amri, Ali Saad, Paul-Martin Holterhus, Moez Gribaa.   

Abstract

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disease of steroid biosynthesis in humans. More than 90% of all CAH cases are caused by mutations of the 21-hydroxylase gene (CYP21A2), and approximately 75% of the defective CYP21A2 genes are generated through an intergenic recombination with the neighboring CYP21A1P pseudogene. In this study, the CYP21A2 gene was genotyped in 50 patients in Tunisia with the clinical diagnosis of 21-hydroxylase deficiency. CYP21A2 mutations were identified in 87% of the alleles. The most common point mutation in our population was the pseudogene specific variant p.Q318X (26%). Three novel single nucleotide polymorphism (SNP) loci were identified in the CYP21A2 gene which seems to be specific for the Tunisian population. The overall concordance between genotype and phenotype was 98%. With this study the molecular basis of CAH has been characterized, providing useful results for clinicians in terms of prediction of disease severity, genetic and prenatal counseling.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841790     DOI: 10.1016/j.gene.2012.07.027

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

2.  A CYP21A2 gene mutation in patients with congenital adrenal hyperplasia. Molecular genetics report from Saudi Arabia.

Authors:  Sarar Mohamed; Suzan El-Kholy; Nasir Al-Juryyan; Abdulrahman M Al-Nemri; Khaled K Abu-Amero
Journal:  Saudi Med J       Date:  2015-01       Impact factor: 1.484

3.  Molecular Analysis of CYP21A2 Gene Mutations among Iraqi Patients with Congenital Adrenal Hyperplasia.

Authors:  Ruqayah G Y Al-Obaidi; Bassam M S Al-Musawi; Munib Ahmed K Al-Zubaidi; Christian Oberkanins; Stefan Németh; Yusra G Y Al-Obaidi
Journal:  Enzyme Res       Date:  2016-09-29

4.  The comparison of the performance of four whole genome amplification kits on ion proton platform in copy number variation detection.

Authors:  Xinyi Zhang; Bo Liang; Xiaoyan Xu; Feifei Zhou; Lingyin Kong; Jingjing Shen; Yingying Xia; Liming Xuan; Yan Mao; Yongfeng Xue; Caixia Liu; Jichun Tan
Journal:  Biosci Rep       Date:  2017-07-07       Impact factor: 3.840

5.  Copy Number Variations in Genetic Diagnosis of Congenital Adrenal Hyperplasia Children.

Authors:  Aisha Tolba; Iman Mandour; Noha Musa; Fatma Elmougy; Mona Hafez; Sahar Abdelatty; Amany Ibrahim; Hend Soliman; Bahaaeldin Labib; Yasmine Elshiwy; Tarek Ramzy; Marwa Elsharkawy
Journal:  Front Genet       Date:  2022-03-02       Impact factor: 4.599

Review 6.  Characteristics and Challenges of Primary Adrenal Insufficiency in Africa: A Review of the Literature.

Authors:  Thabiso R P Mofokeng; Salem A Beshyah; Ian L Ross
Journal:  Int J Endocrinol       Date:  2022-08-24       Impact factor: 2.803

7.  Genetic aetiology of primary adrenal insufficiency in Chinese children.

Authors:  Zhuo Chang; Wei Lu; Zhuhui Zhao; Li Xi; Xiaojing Li; Rong Ye; Jinwen Ni; Zhou Pei; Miaoying Zhang; Ruoqian Cheng; Zhangqian Zheng; Chengjun Sun; Jing Wu; Feihong Luo
Journal:  BMC Med Genomics       Date:  2021-06-30       Impact factor: 3.063

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.